RegenCell BioScience Holdings (RGC)

[shinhari1309]

Founder recently bought US$886k worth of stock.
On the 25th of July, Yat-Gai Au bought around 22k shares on-market at roughly US$39.48 per share. In the last 3 months, they made an even bigger purchase worth US$1.2m. Yat-Gai has been a buyer over the last 12 months, purchasing a net total of US$2.7m worth in shares.

Until the company's market valuation reaches $1 billion, the CEO of RGC vows to assist Regencell by taking a $1 annual salary with no bonuses. Additionally, he has set aside share options for everyone but himself. He had taken the initiative in utilising more than $5.9 million of my personal assets to buy shares on the open market.

Additionally, the management group and directors have agreed to collectively extend the lock-up obligations on their stock options.

About Regencell Bioscience:
The development, investigation, and promotion of TCM for the management of neurocognitive diseases and degeneration, such as attention deficit hyperactivity disorder and autism spectrum disorder, are its primary foci.

Thanks for your support! pic.twitter.com/OEL7M8a4y9

— Yat-Gai Au (@yat_gai) July 27, 2022